| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |